Synaptogyrin-2 (ISO Form 1) as a Drug Target and Biomarker (G9144)

Target Name: SYNGR2

NCBI ID: G9144

SYNGR2

Synaptogyrin-2 (ISO Form 1) as a Drug Target and Biomarker

Synaptogyrin-2 (ISO Form 1) is a protein that is expressed in the rat cerebral cortical layer and is known for its unique structure and function. This protein has been identified as a potential drug target and biomarker for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

Synaptogyrin-2 (ISO Form 1) is a transmembrane protein that is composed of four transmembrane domains and a cytoplasmic tail. It has a unique feature, known as a split transmembrane region, which consists of two distinct transmembrane domains that are connected by a cytoplasmic tail. The split transmembrane region plays a crucial role in the protein's stability and function, as well as its ability to interact with other proteins and molecules.

Drug Target Potential

Synaptogyrin-2 (ISO Form 1) has been identified as a potential drug target due to its unique structure and function. The split transmembrane region allows for the recruitment of various signaling molecules, including tyrosine, which can modulate the activity of other proteins. Additionally, the protein's unique structure may provide a unique binding site for small molecules, such as drugs, which can modulate its function.

One of the most promising aspects of Synaptogyrin-2 (ISO Form 1) as a drug target is its involvement in the development and progression of neurodegenerative disorders. Studies have shown that Synaptogyrin-2 (ISO Form 1) is overexpressed in various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, the protein has been shown to contribute to the misfolding and degradation of neurotransmitter-producing neurons, which may contribute to the progression of neurodegenerative disorders.

Biomarker Potential

Synaptogyrin-2 (ISO Form 1) has also been identified as a potential biomarker for various neurological disorders. The protein has been shown to be expressed in the brain and has been used as a protein biomarker for neurodegenerative disorders. Additionally, the protein has been shown to be involved in the regulation of neurotransmitter release and has been linked to the function of several neurotransmitter systems, including dopamine, serotonin, and GABA.

Conclusion

In conclusion, Synaptogyrin-2 (ISO Form 1) is a protein that has unique structure and function and has been identified as a potential drug target and biomarker for various neurological disorders. The split transmembrane region and the cytoplasmic tail of the protein make it a unique target for small molecules, and its involvement in the development and progression of neurodegenerative disorders makes it an attractive candidate for drug development. Additionally, the protein's role as a biomarker for neurotransmitter systems makes it an important tool for the diagnosis and treatment of neurodegenerative disorders.

FAQs

Q1. What is Synaptogyrin-2 (ISO Form 1)?
A1: Synaptogyrin-2 (ISO Form 1) is a protein that is expressed in the rat cerebral cortical layer and has unique structure and function.

Q2. What are some potential drug targets for Synaptogyrin-2 (ISO Form 1)?
A2: Synaptogyrin-2 (ISO Form 1) has been identified as a potential drug target due to its unique structure and function, including its involvement in the development and progression of neurodegenerative disorders.

Q3. What is the function of Synaptogyrin-2 (ISO Form 1)?
A3: Synaptogyrin-2 (ISO Form 1) is a transmembrane protein that is involved in the regulation of neurotransmitter release and has unique structure and function.

Q4. How is Synaptogyrin-2 (ISO Form 1) involved in the development and progression of

Protein Name: Synaptogyrin 2

Functions: May play a role in regulated exocytosis. In neuronal cells, modulates the localization of synaptophysin/SYP into synaptic-like microvesicles and may therefore play a role in the formation and/or the maturation of this vesicles. May also play a role in GLUT4 storage and transport to the plasma membrane

The "SYNGR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYNGR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets